BioCentury
ARTICLE | Clinical News

CardioFit system: Phase III started

May 2, 2011 7:00 AM UTC

BioControl began the open-label, U.S. and German Phase III INOVATE-HF trial to evaluate CardioFit plus standard of care (SOC) vs. SOC alone in about 650 patients. ...